Zhang, Mingming <br/><br/>
Sirtinol promotes PEPCK1 degradation and inhibits gluconeogenesis by inhibiting deacetylase SIRT2.  [electronic resource] 

 -  Scientific reports  02 2017 
 - 7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/s41598-017-00035-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylation<br/>Animals<br/>Benzamides--pharmacology<br/>Blood Glucose<br/>Gluconeogenesis--drug effects<br/>HEK293 Cells<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>Intracellular Signaling Peptides and Proteins--metabolism<br/>Liver--metabolism<br/>Mice<br/>Naphthols--pharmacology<br/>Phosphoenolpyruvate Carboxykinase (GTP)--metabolism<br/>Sirtuin 2--antagonists & inhibitors